These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21138338)

  • 1. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective.
    Hadker N; Garg S; Costanzo C; Miller JD; Foster T; van der Helm W; Creeden J
    J Med Econ; 2010; 13(4):728-37. PubMed ID: 21138338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective.
    Hadker N; Garg S; Costanzo C; van der Helm W; Creeden J
    Hypertens Pregnancy; 2013 May; 32(2):105-19. PubMed ID: 23725076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
    Schlembach D; Hund M; Schroer A; Wolf C
    BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budget impact analysis of sFlt-1/PlGF ratio as prediction test in Italian women with suspected preeclampsia.
    Frusca T; Gervasi MT; Paolini D; Dionisi M; Ferre F; Cetin I
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2166-2173. PubMed ID: 27737599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK.
    Vatish M; Strunz-McKendry T; Hund M; Allegranza D; Wolf C; Smare C
    Ultrasound Obstet Gynecol; 2016 Dec; 48(6):765-771. PubMed ID: 27300726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of sFlt-1/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals.
    Figueira SF; Wolf C; D'Innocenzo M; de Carvalho JPV; Barbosa MG; Zlotnik E; Cordioli E
    Pregnancy Hypertens; 2018 Jul; 13():30-36. PubMed ID: 30177068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center.
    Caillon H; Tardif C; Dumontet E; Winer N; Masson D
    Ann Lab Med; 2018 Mar; 38(2):95-101. PubMed ID: 29214752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective.
    Hodel M; Blank PR; Marty P; Lapaire O
    Dis Markers; 2019; 2019():4096847. PubMed ID: 31485276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis.
    Duhig KE; Seed PT; Myers JE; Bahl R; Bambridge G; Barnfield S; Ficquet J; Girling JC; Khalil A; Shennan AH; Chappell LC; Hunter RM
    BJOG; 2019 Oct; 126(11):1390-1398. PubMed ID: 31240854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers' perspective.
    Chantraine F; Van Calsteren K; Devlieger R; Gruson D; Keirsbilck JV; Dubon Garcia A; Vandeweyer K; Gucciardo L
    Pregnancy Hypertens; 2021 Dec; 26():31-37. PubMed ID: 34482271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis.
    Waugh J; Hooper R; Lamb E; Robson S; Shennan A; Milne F; Price C; Thangaratinam S; Berdunov V; Bingham J
    Health Technol Assess; 2017 Oct; 21(61):1-90. PubMed ID: 29064366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States.
    Khosla K; Espinoza J; Perlaza L; Gencay M; Mueller AL; Harris JM; Wolf C; Posnett JW; Woelkers DA; Rana S
    Pregnancy Hypertens; 2021 Dec; 26():121-126. PubMed ID: 34749060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(3):1-146. PubMed ID: 37284279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia.
    Schnettler WT; Dukhovny D; Wenger J; Salahuddin S; Ralston SJ; Rana S
    BJOG; 2013 Sep; 120(10):1224-32. PubMed ID: 23647884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis.
    Álvarez-Fernández I; Prieto B; Rodríguez V; Ruano Y; Escudero AI; Álvarez FV
    Clin Chem Lab Med; 2014 Aug; 52(8):1159-68. PubMed ID: 24516004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
    BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia.
    Wright D; Krajewska K; Bogdanova A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):755-61. PubMed ID: 26726123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.